325 related articles for article (PubMed ID: 11095120)
1. Ketorolac-tobramycin combination vs fluorometholone-tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision.
Guzey M; Karadede S; Dogan Z; Satici A
Ophthalmic Surg Lasers; 2000; 31(6):451-6. PubMed ID: 11095120
[TBL] [Abstract][Full Text] [Related]
2. Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification.
Karalezli A; Borazan M; Akova YA
Acta Ophthalmol; 2008 Mar; 86(2):183-7. PubMed ID: 18162061
[TBL] [Abstract][Full Text] [Related]
3. Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification.
Trinavarat A; Atchaneeyasakul LO; Surachatkumtonekul T; Kosrirukvongs P
J Med Assoc Thai; 2003 Feb; 86(2):143-50. PubMed ID: 12678152
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
[TBL] [Abstract][Full Text] [Related]
5. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
Flach AJ; Dolan BJ
Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
[TBL] [Abstract][Full Text] [Related]
7. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs.
Baudouin C; Nordmann JP; Denis P; Creuzot-Garcher C; Allaire C; Trinquand C
Graefes Arch Clin Exp Ophthalmol; 2002 Nov; 240(11):929-35. PubMed ID: 12486516
[TBL] [Abstract][Full Text] [Related]
10. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
Wittpenn JR; Silverstein S; Heier J; Kenyon KR; Hunkeler JD; Earl M;
Am J Ophthalmol; 2008 Oct; 146(4):554-560. PubMed ID: 18599019
[TBL] [Abstract][Full Text] [Related]
11. Effects of intracameral triamcinolone and gentamicin injections following cataract surgery.
Simaroj P; Sinsawad P; Lekhanont K
J Med Assoc Thai; 2011 Jul; 94(7):819-25. PubMed ID: 21774289
[TBL] [Abstract][Full Text] [Related]
12. A comparison of two ophthalmic steroid-antibiotic combinations after cataract surgery.
van Endt JJ; Veraart HG; Kramer R; Janssen AG; Sunder Raj P
Eur J Ophthalmol; 1997; 7(2):144-8. PubMed ID: 9243217
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone-netilmicin: a new ophthalmic steroid-antibiotic combination. Efficacy and safety after cataract surgery.
Russo S; Papa V; Di Bella A; Favero A; Radulescu C; Gafencu O; Carstocea B; Milazzo G
Eye (Lond); 2007 Jan; 21(1):58-64. PubMed ID: 16273088
[TBL] [Abstract][Full Text] [Related]
14. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.
Weber M; Kodjikian L; Kruse FE; Zagorski Z; Allaire CM
Acta Ophthalmol; 2013 Feb; 91(1):e15-21. PubMed ID: 22970738
[TBL] [Abstract][Full Text] [Related]
16. Phase II results of an intraocular steroid delivery system for cataract surgery.
Chang DF; Garcia IH; Hunkeler JD; Minas T
Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
[TBL] [Abstract][Full Text] [Related]
17. Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial.
Chatziralli IP; Papazisis L; Sergentanis TN
Ophthalmologica; 2011; 225(2):89-94. PubMed ID: 20881443
[TBL] [Abstract][Full Text] [Related]
18. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
Miyake K; Ota I; Miyake G; Numaga J
J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic fluorometholone-gentamicin versus ophthalmic betamethasone-gentamicin following cataract surgery.
Steinbach PD; Bauer J; Sunder Raj P
Ocul Immunol Inflamm; 1997 Mar; 5(1):51-4. PubMed ID: 9145693
[TBL] [Abstract][Full Text] [Related]
20. Fixed-dose combination of 0.1% diclofenac plus 0.3% tobramycin ophthalmic solution for inflammation after cataract surgery: a randomized, comparative, active treatment-controlled trial.
Barraquer RI; Alvarez de Toledo JP; Montané D; Escoto RM; Garcia Torres C; Bennani-Tazzi M
Eur J Ophthalmol; 1998; 8(3):173-8. PubMed ID: 9793772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
